According to a publication from KSPR 33, a drug that was once given away free of charge on a provisional basis to people with Lambert-Eaton myasthenic syndrome (or LEMS) is…
According to a publication from the Stamford Advocate, the Connecticut-based Alliance for Cancer Gene Therapy (or ACGT) has welcomed a new president and CEO in Kevin Honeycutt. Honeycutt has announced…
According to an article from R&D, researchers at the New York City-based Icahn School of Medicine at Mount Sinai have entered an agreement with two pharmaceutical companies to aid in…
According to a press release from Danish biotechnology company Bavarian Nordic, ten individuals with chordomas have been successfully recruited for a Phase 2 study of the drug candidate BN-Brachyury. About…
According to a publication from OncLive, the FDA has granted TG Therapeutics' experimental marginal zone lymphoma drug Umbralisib a "Breakthrough Therapy" designation. About Marginal Zone Lymphoma Marginal zone lymphoma (or…
The History of West Nile Virus The West Nile Virus (WNV) was named for the location where it was originally found- the West Nile district in Uganda. It was discovered…
According to a publication from BusinessWire, the Maryland-based pharmaceutical company OncoImmune, Inc. has announced successful phase 2 trial results for its acute graft versus host disease (GVHD) drug CD24Fc. Graft…
The most common treatment for someone who is discovered to have early stage kidney cancer is surgery. The patient's tumors and a part of their kidneys are removed through a…
According to an article from Pharmaceutical Daily, the Seattle-based drug company Sound Pharmaceuticals is set to soon begin a phase 2 clinical study for a cystic fibrosis (CF) drug candidate…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
